PortfoliosLab logoPortfoliosLab logo
GRMN vs. GILD
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

GRMN vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Garmin Ltd. (GRMN) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

GRMN vs. GILD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GRMN
Garmin Ltd.
17.56%-0.06%63.25%43.12%-30.20%15.90%25.86%58.13%9.84%27.60%
GILD
Gilead Sciences, Inc.
14.96%36.59%18.68%-1.99%23.63%29.95%-6.70%7.88%-9.92%2.96%

Fundamentals

Market Cap

GRMN:

$46.04B

GILD:

$175.80B

EPS

GRMN:

$8.60

GILD:

$6.79

PE Ratio

GRMN:

27.64

GILD:

20.67

PEG Ratio

GRMN:

2.22

GILD:

0.05

PS Ratio

GRMN:

6.35

GILD:

5.98

PB Ratio

GRMN:

5.13

GILD:

7.77

Total Revenue (TTM)

GRMN:

$7.25B

GILD:

$29.44B

Gross Profit (TTM)

GRMN:

$4.26B

GILD:

$23.79B

EBITDA (TTM)

GRMN:

$2.07B

GILD:

$12.90B

Returns By Period

In the year-to-date period, GRMN achieves a 17.56% return, which is significantly higher than GILD's 14.96% return. Over the past 10 years, GRMN has outperformed GILD with an annualized return of 22.84%, while GILD has yielded a comparatively lower 7.81% annualized return.


GRMN

1D
2.40%
1M
-6.54%
YTD
17.56%
6M
-6.14%
1Y
10.99%
3Y*
35.56%
5Y*
14.82%
10Y*
22.84%

GILD

1D
0.67%
1M
-5.95%
YTD
14.96%
6M
27.78%
1Y
29.43%
3Y*
23.25%
5Y*
20.53%
10Y*
7.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GRMN vs. GILD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GRMN
GRMN Risk / Return Rank: 4949
Overall Rank
GRMN Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
GRMN Sortino Ratio Rank: 4444
Sortino Ratio Rank
GRMN Omega Ratio Rank: 4848
Omega Ratio Rank
GRMN Calmar Ratio Rank: 5151
Calmar Ratio Rank
GRMN Martin Ratio Rank: 5151
Martin Ratio Rank

GILD
GILD Risk / Return Rank: 7373
Overall Rank
GILD Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
GILD Sortino Ratio Rank: 7070
Sortino Ratio Rank
GILD Omega Ratio Rank: 6464
Omega Ratio Rank
GILD Calmar Ratio Rank: 7777
Calmar Ratio Rank
GILD Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GRMN vs. GILD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Garmin Ltd. (GRMN) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GRMNGILDDifference

Sharpe ratio

Return per unit of total volatility

0.31

1.02

-0.71

Sortino ratio

Return per unit of downside risk

0.62

1.63

-1.01

Omega ratio

Gain probability vs. loss probability

1.10

1.19

-0.09

Calmar ratio

Return relative to maximum drawdown

0.40

2.07

-1.67

Martin ratio

Return relative to average drawdown

0.86

5.62

-4.76

GRMN vs. GILD - Sharpe Ratio Comparison

The current GRMN Sharpe Ratio is 0.31, which is lower than the GILD Sharpe Ratio of 1.02. The chart below compares the historical Sharpe Ratios of GRMN and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


GRMNGILDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.31

1.02

-0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.50

0.86

-0.37

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.81

0.31

+0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

0.39

+0.06

Correlation

The correlation between GRMN and GILD is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

GRMN vs. GILD - Dividend Comparison

GRMN's dividend yield for the trailing twelve months is around 1.52%, less than GILD's 2.27% yield.


TTM20252024202320222021202020192018201720162015
GRMN
Garmin Ltd.
1.52%1.70%1.44%2.27%3.10%1.92%2.01%2.30%3.32%3.42%4.21%5.41%
GILD
Gilead Sciences, Inc.
2.27%2.57%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%

Drawdowns

GRMN vs. GILD - Drawdown Comparison

The maximum GRMN drawdown since its inception was -87.71%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for GRMN and GILD.


Loading graphics...

Drawdown Indicators


GRMNGILDDifference

Max Drawdown

Largest peak-to-trough decline

-87.71%

-70.83%

-16.88%

Max Drawdown (1Y)

Largest decline over 1 year

-27.97%

-13.77%

-14.20%

Max Drawdown (5Y)

Largest decline over 5 years

-54.63%

-26.59%

-28.04%

Max Drawdown (10Y)

Largest decline over 10 years

-54.63%

-36.01%

-18.62%

Current Drawdown

Current decline from peak

-7.80%

-9.44%

+1.64%

Average Drawdown

Average peak-to-trough decline

-31.70%

-22.20%

-9.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.05%

5.08%

+7.97%

Volatility

GRMN vs. GILD - Volatility Comparison

Garmin Ltd. (GRMN) has a higher volatility of 9.08% compared to Gilead Sciences, Inc. (GILD) at 6.36%. This indicates that GRMN's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


GRMNGILDDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.08%

6.36%

+2.72%

Volatility (6M)

Calculated over the trailing 6-month period

23.96%

18.91%

+5.05%

Volatility (1Y)

Calculated over the trailing 1-year period

35.86%

29.01%

+6.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.07%

23.90%

+6.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.21%

25.63%

+2.58%

Financials

GRMN vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Garmin Ltd. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B6.00B7.00B8.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
2.12B
7.93B
(GRMN) Total Revenue
(GILD) Total Revenue
Values in USD except per share items

GRMN vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Garmin Ltd. and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
59.2%
86.8%
Portfolio components
GRMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Garmin Ltd. reported a gross profit of 1.26B and revenue of 2.12B. Therefore, the gross margin over that period was 59.2%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a gross profit of 6.88B and revenue of 7.93B. Therefore, the gross margin over that period was 86.8%.

GRMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Garmin Ltd. reported an operating income of 614.15M and revenue of 2.12B, resulting in an operating margin of 28.9%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported an operating income of 2.96B and revenue of 7.93B, resulting in an operating margin of 37.4%.

GRMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Garmin Ltd. reported a net income of 528.68M and revenue of 2.12B, resulting in a net margin of 24.9%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Gilead Sciences, Inc. reported a net income of 2.18B and revenue of 7.93B, resulting in a net margin of 27.6%.